Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE -- Ignore unavailable to you. Want to Upgrade?

To: Douglas who wrote (354)	4/30/1998 8:57:00 AM
From: Susan Saline	Respond to of 670

ahhh short interest declining, I'm not surprised :o) news today the paragraph in bold is why I am long PRCY New Member Joins Board of Directors Company Strengthens Cosmetic Surgery Market Expertise REDMOND, Wash., April 30 /PRNewswire/ -- ProCyte Corporation (Nasdaq: PRCY - news) today announced that Dr. Matt L. Leavitt has joined their Board of Directors. Dr. Leavitt is the founder and Medical Director of Advanced Dermatology, Advanced Cosmetic Surgery, Medical Hair Restoration and affiliated companies with offices in over 30 cities located nationally and internationally. He is the current Chairman of the World Association of Hair Restoration Surgeons and an advisor and trustee for the American Academy of Aesthetic and Restorative Surgery. Dr. Leavitt is a graduate from the University of Michigan and Michigan State University College of Osteopathic Medicine and is Board-Certified in Dermatology. ''I am very pleased to have the experience and insights that Dr. Leavitt brings to our Board,'' said Jack Clifford, President and CEO. ''Our recent new product releases and HumaTech acquisition solidify our position in the Cosmetic Surgery market, and Matt will help us define ongoing growth opportunities''. This report may contain forward-looking statements. The Company's results may vary significantly from quarter to quarter and will depend among other factors on product launches and market acceptance, manufacturing contracts and distribution agreements. ProCyte Corporation is a healthcare company which develops, manufactures and markets products for tissue repair, skin health and hair care. The Company's products incorporate its patented copper peptide technology and are marketed both directly and through distribution partners. Sue